# The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease

> **NCT07182942** · PHASE4 · RECRUITING · sponsor: **Chujin Cao** · enrollment: 120 (estimated)

## Conditions studied

- CKD
- Drug Effect

## Interventions

- **DRUG:** Xiqing
- **DRUG:** probiotics

## Key facts

- **NCT ID:** NCT07182942
- **Lead sponsor:** Chujin Cao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-07
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182942, "The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT07182942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*